Cargando…
Radiotherapy Versus Surgery–Which Is Better for Patients With T1-2N0M0 Glottic Laryngeal Squamous Cell Carcinoma? Individualized Survival Prediction Based on Web-Based Nomograms
BACKGROUND: Both radiotherapy and surgery are now recommended for early stage glottic laryngeal squamous cell carcinoma (LSCC), and both have their own advantages in patients with different characteristics. For each patient, it is hard to determine whether radiotherapy or surgery is more appropriate...
Autores principales: | Du, Yajing, Shao, Shali, Lv, Minghe, Zhu, Yi, Yan, Li, Qiao, Tiankui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7507900/ https://www.ncbi.nlm.nih.gov/pubmed/33014833 http://dx.doi.org/10.3389/fonc.2020.01669 |
Ejemplares similares
-
Survival outcomes in patients with T3-4aN0M0 glottic laryngeal squamous cell carcinoma and evaluation of postoperative radiotherapy
por: Zhou, Jian, et al.
Publicado: (2022) -
Evaluating Post-Radiotherapy Laryngeal Function with Laryngeal Videostroboscopy in Early Stage Glottic Cancer
por: Marciscano, Ariel E., et al.
Publicado: (2017) -
Oncological outcome of vocal cord-only radiotherapy for cT1-T2 glottic laryngeal squamous cell carcinoma
por: de Ridder, Mischa, et al.
Publicado: (2023) -
Clinical analysis of EBRT vs TLM in the treatment of early (T1-T2N0) glottic laryngeal cancer
por: Shen, Jing, et al.
Publicado: (2020) -
WRAP53β, survivin and p16(INK4a) expression as potential predictors of radiotherapy/chemoradiotherapy response in T2N0-T3N0 glottic laryngeal cancer
por: Tiefenböck-Hansson, Katharina, et al.
Publicado: (2017)